Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Direct and Catalytic C ‐Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside**
2021 StandoutNobel
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication
2018 StandoutNobel
Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment
2014
Structural Insights into RNA Recognition by RIG-I
2011
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure
2013 StandoutNobel
Evolutionarily Conserved Roles of the Dicer Helicase Domain in Regulating RNA Interference Processing
2014 StandoutNobel
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs
2017
Pattern Recognition Receptors and Inflammation
2010 Standout
Hepatitis C Virus Proteins: From Structure to Function
2013
Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
2015
Metazoan MicroRNAs
2018 Standout
New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges
2014
Resistance to nucleotide analogue inhibitors of hepatitis C virus NS5B: mechanisms and clinical relevance
2014
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin
2015 StandoutNobel
Cardiac glycosides are potent inhibitors of interferon-β gene expression
2010
Structural Mechanism of RNA Recognition by the RIG-I-like Receptors
2008
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
2013
Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense
2011 StandoutNobel
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Hepatitis C Virus-Specific Directly Acting Antiviral Drugs
2013
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Structural Determinants in Human DNA Polymerase γ Account for Mitochondrial Toxicity from Nucleoside Analogs
2003
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Structure of replicating SARS-CoV-2 polymerase
2020 Nature
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Crystallographic Fragment Screening and Structure-Based Optimization Yields a New Class of Influenza Endonuclease Inhibitors
2013
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
2011 StandoutNobel
RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP
2010
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA
2011
Host Innate Immune Receptors and Beyond: Making Sense of Microbial Infections
2008
ATP-Dependent Effector-like Functions of RIG-I-like Receptors
2015 StandoutNobel
Current race in the development of DAAs (direct-acting antivirals) against HCV
2014
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
3d Transition Metals for C–H Activation
2018 Standout
Inhibitors of the Tick-Borne, Hemorrhagic Fever-Associated Flaviviruses
2014
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro
2012 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
ATP-independent diffusion of double-stranded RNA binding proteins
2012 StandoutNobel
Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B Protein
2013
A bacterial Argonaute with noncanonical guide RNA specificity
2016 StandoutNobel
Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B
2014 StandoutNobel
Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase
2013
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
RNA Scanning of a Molecular Machine with a Built-in Ruler
2016 StandoutNobel
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
2020
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
Cytosolic Viral Sensor RIG-I Is a 5'-Triphosphate–Dependent Translocase on Double-Stranded RNA
2009 Science
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Viral Quasispecies Evolution
2012
Cobalt-Catalyzed Remote C-4 Functionalization of 8-Aminoquinoline Amides with Ethers via C–H Activation under Visible-Light Irradiation. Access to α-Heteroarylated Ether Derivatives
2018
A Derivate of the Antibiotic Doxorubicin Is a Selective Inhibitor of Dengue and Yellow Fever Virus Replication In Vitro
2010
Novel Therapies for Hepatitis C: Insights from the Structure of the Virus
2011
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus
2016 StandoutNobel
Favipiravir elicits antiviral mutagenesis during virus replication in vivo
2014
Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA
2017
ATP-sensitive potassium channel (K ATP )–dependent regulation of cardiotropic viral infections
2011 StandoutNobel
Works of Jérôme Deval being referenced
Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase
2018
Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-d-2′-ethynyl-7-deaza-adenosine triphosphate
2010
Characterization of the Elongation Complex of Dengue Virus RNA Polymerase
2010
The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
2013
The Molecular Mechanism of Multidrug Resistance by the Q151M Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Its Suppression Using α-Boranophosphate Nucleotide Analogues
2002
Essential Role of the N-terminal Domain in the Regulation of RIG-I ATPase Activity
2008
New opportunities in anti-hepatitis C virus drug discovery: Targeting NS4B
2011
Antimicrobial Strategies
2009
Nucleosides for the treatment of respiratory RNA virus infections
2018
Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2′- C -Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases
2015
Synthesis and Anti-Influenza Activity of Pyridine, Pyridazine, and Pyrimidine C-Nucleosides as Favipiravir (T-705) Analogues
2016
Biochemical Study of the Comparative Inhibition of Hepatitis C Virus RNA Polymerase by VX-222 and Filibuvir
2011
Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase
2012
Efficiency of Incorporation and Chain Termination Determines the Inhibition Potency of 2′-Modified Nucleotide Analogs against Hepatitis C Virus Polymerase
2014
Mechanism of Hepatitis C Virus RNA Polymerase Inhibition with Dihydroxypyrimidines
2009
Pyrophosphorolytic Excision of Nonobligate Chain Terminators by Hepatitis C Virus NS5B Polymerase
2007